Gapping up
In reaction to strong earnings/guidance: DNDN +9.4%, PERI +7.5%, MGA +3.2%, (light volume).
Metals/mining stocks trading higher: AU +5.2%, IAG +5.1%, EGO +5.1%, HMY +4.6%, KGC +4.2%, GG +4%, GOLD +3.8%, AG 3.5% (First Majestic Silver promotes Salvador Garca to the role of Chief Operating Officer starting July 1, 2014 ), RGLD +3.3%, CDE +2.7%, SLW +2.6%, GDX +2.4%, GLD +1.6%, SLV +1.5%.
Other news: NQ 10.8% (following late sell-off on Friday), PCC 6.2% (declares special dividend and announces that it will transfer to NASDAQ Global Market), ARRY 5.8% (rovides Clinical Update On ARRY-502 For Asthma At Scientific Meeting; ARRY-502 met the primary endpoint in the trial, Secondary efficacy endpoints also achieved statistical significance), CNAT 5.2% (Conatus Pharma extends liver disease reach with Phase 2 NAFLD/NASH trial ), GALE 4.8% ( launches Galena Patient Services), ASNA 3.3% (favorable mention on Friday's Mad Money), SGMO 3.3% (still checking), LO 1.9% (still checking), STO 1.7% (reported that Zafarani reservoir in Tanzania Block 2 successfully tested), WPRT 1.2% (Westport and Delphi (DLPH) Sign Joint Development Agreement to Commercialize Natural Gas Injector Technology), ISIS 1.1% (Earns $1 Million from GSK for Advancing ISIS-TTR Rx), JOSB 0.8% (Men's Wearhouse Announces Non-Disclosure Agreement With Jos. A. Bank).
Analyst comments: ASPX +6.9% (initiated with an Outperform at BMO Capital Mkts ), RVNC +5.2% (initiated with an Outperform at BMO Capital Mkts, initiated with a Overweight at Piper Jaffray; initiated with an Outperform at Cowen), ACMP +0.6% (upgraded to Buy at Wunderlich)
Metals/mining stocks trading higher: AU +5.2%, IAG +5.1%, EGO +5.1%, HMY +4.6%, KGC +4.2%, GG +4%, GOLD +3.8%, AG 3.5% (First Majestic Silver promotes Salvador Garca to the role of Chief Operating Officer starting July 1, 2014 ), RGLD +3.3%, CDE +2.7%, SLW +2.6%, GDX +2.4%, GLD +1.6%, SLV +1.5%.
Other news: NQ 10.8% (following late sell-off on Friday), PCC 6.2% (declares special dividend and announces that it will transfer to NASDAQ Global Market), ARRY 5.8% (rovides Clinical Update On ARRY-502 For Asthma At Scientific Meeting; ARRY-502 met the primary endpoint in the trial, Secondary efficacy endpoints also achieved statistical significance), CNAT 5.2% (Conatus Pharma extends liver disease reach with Phase 2 NAFLD/NASH trial ), GALE 4.8% ( launches Galena Patient Services), ASNA 3.3% (favorable mention on Friday's Mad Money), SGMO 3.3% (still checking), LO 1.9% (still checking), STO 1.7% (reported that Zafarani reservoir in Tanzania Block 2 successfully tested), WPRT 1.2% (Westport and Delphi (DLPH) Sign Joint Development Agreement to Commercialize Natural Gas Injector Technology), ISIS 1.1% (Earns $1 Million from GSK for Advancing ISIS-TTR Rx), JOSB 0.8% (Men's Wearhouse Announces Non-Disclosure Agreement With Jos. A. Bank).
Analyst comments: ASPX +6.9% (initiated with an Outperform at BMO Capital Mkts ), RVNC +5.2% (initiated with an Outperform at BMO Capital Mkts, initiated with a Overweight at Piper Jaffray; initiated with an Outperform at Cowen), ACMP +0.6% (upgraded to Buy at Wunderlich)